Archive

Edmonds, Washington / Son, Norway – July 2019   Modus Health earns first clinical care contract with CatoSenteret in Norway. CatoSenteret will be working with Modus Health in the development of its Acute Care System in order to encourage increased patient mobility during their inpatient stay. Modus Health’s CEO, Teri Chou, states “Jan and his team at CatoSenteret are true innovators who are willing to work through the barriers of change for the benefit of their patients. We are excited to partner with them on this critical project.”

The goal of CatoSenteret is to improve patient health before they leave the hospital. Increased mobility plays a key role in achieving this outcome. Several publications have already shown that increased ambulation as measured by StepWatch is associated with reduced length of stay (McCullagh, 2016), risk of readmission (Fisher, 2016), and improved outcomes (Hornby, 2015). In addition, a study using many different activity monitors during inpatient care found that only StepWatch detected steps in every patient (Treacy, 2017). StepWatch has also been demonstrated to be the only accurate monitor for measuring walking in daily life (Toth, 2018). Modus Health is leveraging StepWatch’s unique accuracy and proven digital biomarkers to improve healthcare through cost-effective platforms. Modus Health’s goal is to become integrated into routine clinical care worldwide.

Jan Nordvik, CEO of the Norwegian rehabilitation center, says of the new collaboration: “The StepWatch is the most precise activity sensor that we are aware of. In clinical work this level of precision is a necessity. In addition, Teri and the Modus Health group are a great innovative team that we are certain will help us to move into a new generation of health care systems where sensor technology is essential to proving the quality of the care for our patients”.

###

References:
R. McCullagh, C. Dillon, D. Dahly, N. F. Horgan, S. Timmons. Walking in hospital is associated with a shorter length of stay in older medical inpatients. Physiological measurement 2016; 37(10):1872-1884.
S. R. Fisher, J. E. Graham, K. J. Ottenbacher, R. Deer, G. V. Ostir. Inpatient Walking Activity to Predict Readmission in Older Adults. Arch Phys Med Rehabil 2016; 97(9 Suppl):S226-31.
T. G. Hornby, C. L. Holleran, A. L. Leddy, et al. Feasibility of Focused Stepping Practice During Inpatient Rehabilitation Poststroke and Potential Contributions to Mobility Outcomes. Neurorehabil Neural Repair 2015; 29(10):923-32.
D. Treacy, L. Hassett, K. Schurr, S. Chagpar, S. S. Paul, C. Sherrington. Validity of Different Activity Monitors to Count Steps in an Inpatient Rehabilitation Setting. Phys Ther 2017; 97(5):581-588.
L. P. Toth, S. Park, C. M. Springer, M. D. Feyerabend, J. A. Steeves, D. R. Bassett. Video-Recorded Validation of Wearable Step Counters under Free-living Conditions. Med Sci Sports Exerc 2018.

Edmonds, Washington / Son, Norway – July 2019   Modus Health earns first clinical care contract with CatoSenteret in Norway. CatoSenteret will be working with Modus Health in the development of its Acute Care System in order to encourage increased patient mobility during their inpatient stay. Modus Health’s CEO, Teri Chou, states “Jan and his team…

Read More

Modus Health was one of four companies interviewed in Clinical OMICs Wearable Data Revolution. Our unique walking algorithm has demonstrated digital biomarkers in many patient conditions (e.g. COPD, CMT, inpatient care, post-stroke, CMT, DMD) for applications in pharmaceutical trials and clinical care.  Contact [email protected] for more information.…

Read More

Edmonds, Washington – July 1, 2018  Modus Health hires Chris Green as it’s CTO. As one of the original founding employees of Modus Health from 2013 – 2015, Chris successfully transitioned StepWatch to a new manufacturer and led quality control and product development. From 2015-2016, Chris was acting CTO of a presidential candidate campaign and…

Read More

Edmonds, Washington – December 1, 2017   Following earning Modus Health’s first pharmaceutical contract, Dr. Teri Chou has been promoted from Chief Scientific Officer to CEO. Dr. Chou was a founding employee of Modus Health in 2013 as Director of Clinical Research. She stayed during the restructure of 2016 as the remaining employee. During this time,…

Read More

Washington, D.C. October 2, 2014 – modus health, llc, a digital health company focused on providing accurate and actionable physical activity data to inform clinical decision making and improve patient outcomes, announced today the formation of its Corporate Advisory Board with eight key appointments. “We are honored to have the support, input and commitment from…

Read More

At the beginning of this month, MobiHealthNews noted in an In-Depth report that a new class of wireless, wearable activity tracker is increasingly finding its way into the clinical space, especially to help people with movement disorders or lower body injuries. That trend just got a big boost from the US Department of Veteran Affairs,…

Read More